(Q33668908)

28 July 2017

title

Cognitive deficits in multiple sclerosis: a systematic review (English)

1 reference

28 July 2017

0 references

1 reference

Maria Lúcia Brito Ferreira

1

1 reference

28 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20730323

21 June 2024

publication date

1 August 2010

1 reference

Arquivos de Neuro-Psiquiatria

28 July 2017

published in

1 reference

28 July 2017

volume

68

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

632-641

1 reference

Cognitive impairment in multiple sclerosis

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Are there protective treatments for cognitive decline in MS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Diagnostics of cognitive dysfunctions in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Cognition in the early stage of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Relationships between information processing, depression, fatigue and cognition in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Cognitive impairment and decline in different MS subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Cognitive profile of patients with relapsing remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Attention impairment associated with relapsing-remitting multiple sclerosis patients with mild incapacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Cognitive impairment in different MS subtypes and clinically isolated syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Effects of donepezil on memory and cognition in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Executive function in multiple sclerosis. The role of frontal lobe pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Corpus callosum damage and cognitive dysfunction in benign MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Activity of attention related structures in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Effect of interferon-beta-1b on cognitive functions in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Cognitive changes in early MS: a call for a common framework.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Distinct Neurocognitive Profiles in Multiple Sclerosis Subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

The neuropsychiatry of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

FLAIR lesion volume in multiple sclerosis: relation to processing speed and verbal memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000400029

Cognitive impairment in multiple sclerosis

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1590/S0004-282X2010000400029

Memory interference in multiple sclerosis

21 June 2024

12

1 reference

https://api.crossref.org/works/10.1590/S0004-282X2010000400029

Cognitive dysfunction in multiple sclerosis: natural history and impact on productive living

21 June 2024

32

1 reference

https://api.crossref.org/works/10.1590/S0004-282X2010000400029

21 June 2024

Identifiers

1 reference

28 July 2017

1 reference